John Maddox Offers Surprising Insights Into His

In 1955, a puckish, 30-year-old Weishman resigned as lecturer in theoretical physics at the University of Manchester to become science correspondent of the Manchester Guardian. Unwittingly, the energetically eclectic John Maddox thus took his first step toward the editorial chair of Nature, which he has occupied with distinction on two occasions—between 1966 and 1973, and from 1980 until the present. A robust defender of what he calls “the scientific enterprise,” Maddox has

Written byBernard Dixon
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

A robust defender of what he calls “the scientific enterprise,” Maddox has played many other roles in science and public affairs He was an affiliate of New York’s Rockefeller Institute in 1962-63, director of London’s Nuffield Found ation from 1975 to 1980, and a public interest representative on the UK Genetic Manipulation Advisory Group from 1976 to 1980. Maddox was also managing director of Macmillan Journal’s Ltd., a publishing house from 1970 to 1972 and chairman of Maddox Editorial Ltd. (whose publications included the European Gazette) from 1972 to 1974. His books include The Spread of Nuclear Weapons (written with Leonard Beaton and published in 1962), The Doomsday Syndrome (1972) and Beyond the Energy Crisis (1975).

During the reign of John Maddox, Nature has greatly extended its news coverage, doubled in circulation, and now sells 33,530 copies each week (14,887 of them in the United States). The editor of what ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies